FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: January 31, 2005 Estimated average burden hours per response... 0.5

(Print or Type Responses)

1. Name and Address of Reporting Person * Silva Francisco   2. Issuer Name and Ticker or Trading Symbol BioRestorative Therapies, Inc. [BRTX] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director _____ 10% Owner __X__ Officer (give title below) _____ Other (specify below) VP of Research and Development (Last) (First) (Middle) 40 MARCUS DRIVE 3. Date of Earliest Transaction (Month/Day/Year) 06/10/2016 (Street) MELVILLE, NY 11747 4. If Amendment, Date Original Filed(Month/Day/Year) 6. Individual or Joint/Group Filing(Check Applicable Line) _X_ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person (City) (State) (Zip) Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned

1.Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.		SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 3)

2. Conversion or Exercise Price of Derivative Security

3. Transaction Date (Month/Day/Year)

3A. Deemed Execution Date, if any (Month/Day/Year)

4. Transaction Code (Instr. 8)

5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5)

6. Date Exercisable and Expiration Date (Month/Day/Year)

7. Title and Amount of Underlying Securities (Instr. 3 and 4)

8. Price of Derivative Security (Instr. 5)

9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)

10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)

11. Nature of Indirect Beneficial Ownership (Instr. 4)

Code

V

(A)

(D)

Date Exercisable

Expiration Date

Title

Amount or Number of Shares

Stock Option

$ 10

(1)

04/04/2021

Common Stock

4,000

4,000

D

Stock Option

$ 25

06/24/2011

06/23/2021

Common Stock

150

150

D

Stock Option

$ 20

11/16/2011

11/15/2021

Common Stock

1,000

1,000

D

Stock Option

$ 21

(2)

02/09/2022

Common Stock

2,000

2,000

D

Stock Option

$ 28

(3)

05/02/2022

Common Stock

5,500

5,500

D

Stock Option

$ 30

(4)

12/07/2022

Common Stock

4,000

4,000

D

Stock Option

$ 12

(5)

10/04/2023

Common Stock

5,000

5,000

D

Stock Option

$ 13

(6)

02/18/2024

Common Stock

12,500

12,500

D

Stock Option

$ 10.6

03/12/2014

03/11/2024

Common Stock

2,000

2,000

D

Stock Option

$ 28

04/14/2014

05/02/2022

Common Stock

2,000

2,000

D

Stock Option

$ 6.6

(7)

10/23/2024

Common Stock

37,500

37,500

D

Stock Option

$ 7

(8)

09/04/2025

Common Stock

25,000

25,000

D

Stock Option

$ 3.73

06/10/2016

A

60,000

(9)

06/10/2026

Common Stock

60,000

$ 0

60,000

D

Reporting Owners

Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
Silva Francisco 40 MARCUS DRIVE MELVILLE, NY 11747			VP of Research and Development

Signatures

/s/ Francisco Silva		06/14/2016
**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 4(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	The option is exercisable to the extent of 2,000 shares on each of April 5, 2011 and April 5, 2012.
(2)	The option is exercisable to the extent of 1,000 shares on each of February 10, 2012 and February 10, 2013.
(3)	The option is exercisable to the extent of 500 shares on each of May 3, 2013, May 3, 2014 and May 3, 2015, became exercisable to the extent of 1,000 shares based on the satisfaction of certain conditions and is exercisable to the extent of 3,000 shares subject to the satisfaction of certain conditions.
(4)	The option is exercisable to the extent of 2,000 shares on each of December 7, 2012 and December 7, 2013.
(5)	The option is exercisable to the extent of 2,500 shares on each of October 4, 2013 and October 4, 2014.
(6)	The option is exercisable to the extent of 4,167 shares on each of February 18, 2014 and February 18, 2015, and 4,166 shares on February 18, 2016.
(7)	The option is exercisable to the extent of 12,500 shares on each of October 23, 2015, October 23, 2016 and October 23, 2017.
(8)	The option is exercisable to the extent of 8,334 shares on September 4, 2016 and 8,333 shares on each of September 4, 2017 and September 4, 2018.
(9)	The option is exercisable to the extent of 20,000 shares on each of June 10, 2017, June 10, 2018 and June 10, 2019.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.